Form 4: Alpha Cognition Grants Equity to VP Finance

Alpha Cognition Inc. granted 20,579 common shares and 15,982 stock options to VP Finance and Accounting Henry Huy Du as part of an equity compensation plan.

Summary

• Henry Huy Du, VP Finance and Accounting of Alpha Cognition Inc., was granted 20,579 common shares and 15,982 common share options.
• The common shares are Restricted Stock Units (RSUs) that vest in three equal annual installments: 1/3 on January 9, 2027, 1/3 on January 9, 2028, and 1/3 on January 9, 2029.
• The common share options have an exercise price of $6.56 and will vest 1/3 on January 9, 2027, with the remainder vesting in equal quarterly installments thereafter.
• The options expire on January 9, 2036.
• The transaction date for both grants was January 9, 2026.

Sentiment

Score: 6

Explanation: The filing reports a routine equity grant to a key executive, which is generally a positive for aligning management incentives with shareholder interests, though it introduces potential future dilution. It's a standard corporate action.

Positives

• The grants align the interests of a key executive, Henry Huy Du, with those of shareholders, incentivizing long-term performance.
• Equity compensation is a standard practice for retaining and motivating senior management.

Negatives

• The issuance of new shares and options could lead to future dilution for existing shareholders if the options are exercised and RSUs vest.
• The value of the compensation is tied to the future stock performance, which carries inherent market risk.

Risks

• Future stock price volatility could impact the value of the granted equity for the executive.
• Potential dilution from the vesting of RSUs and exercise of options could slightly reduce the ownership percentage of existing shareholders.

Future Outlook

The long-term vesting schedules for both the restricted stock units and stock options suggest a strategic intent to retain key management and align their incentives with the company's sustained growth and performance over several years.

Industry Context

Equity compensation, including restricted stock units and stock options, is a prevalent practice across various industries, particularly in biotechnology and pharmaceutical sectors like Alpha Cognition, to attract, retain, and motivate executive talent. These grants are designed to align executive interests with long-term shareholder value creation.

Comparison to Industry Standards

• The use of a combination of Restricted Stock Units (RSUs) and stock options for executive compensation is a common practice, comparable to compensation structures seen at similar-stage biotech companies.
• The vesting schedule, typically over 3-4 years, is standard for long-term incentive plans aimed at executive retention and performance alignment. For example, companies like Biogen or Amgen often use similar multi-year vesting schedules for their executive equity grants.
• The exercise price of $6.56 for the options is likely based on the market price of Alpha Cognition Inc. shares on the grant date, which is standard practice to ensure options are "at-the-money" or "in-the-money" at grant.

Stakeholder Impact

• Shareholders: Potential future dilution from the vesting of RSUs and exercise of options; improved alignment of executive interests with long-term shareholder value.
• Employees: Standard executive compensation practices can positively influence overall employee morale and retention strategies.

Next Steps

• Vesting of 1/3 of common shares and 1/3 of common share options on January 9, 2027.
• Subsequent quarterly vesting of the remaining common share options.
• Subsequent annual vesting of the remaining common shares on January 9, 2028, and January 9, 2029.

Key Dates

Keywords

Alpha Cognition, ACOG, Henry Huy Du, VP Finance, equity compensation, stock options, restricted stock units, RSU, insider transaction, Form 4, executive compensation